SCHEMBL20864356

SCHEMBL20864356

CCBc1ccc(F)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACHE P22303 1/20 0.39
▸ LMNA P02545 1/20 0.37
▸ IDO1 P14902 2/20 0.35
▸ LOXL2 Q9Y4K0 1/20 0.35
▸ TRPA1 O75762 1/20 0.34
▸ TAAR1 Q96RJ0 3/20 0.33
▸ HTR7 P34969 1/20 0.33
▸ CA1 P00915 1/20 0.33
▸ CA2 P00918 1/20 0.33
▸ CA7 P43166 1/20 0.33
▸ CA9 Q16790 1/20 0.33
▸ RIPK1 Q13546 1/20 0.32
▸ L3MBTL1 Q9Y468 2/20 0.31
▸ CYP1A2 P05177 1/20 0.31
▸ CYP2D6 P10635 1/20 0.31
▸ CYP2C19 P33261 1/20 0.31
▸ TDP1 Q9NUW8 1/20 0.31
▸ NFE2L2 Q16236 2/20 0.31
▸ AOC3 Q16853 1/20 0.31
▸ AGXT P21549 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Alcohol SCHEMBL28041790 0.70 ACHE (0.53) ACHELMNAIDO1LOXL2TRPA1
SCHEMBL14085645 0.69 ACHE (0.52) ACHELMNAIDO1LOXL2CYP2D6
SCHEMBL6346474 0.69 — —
SCHEMBL2065074 0.67 CA1 (0.42) ACHEIDO1LOXL2TAAR1CA1
Ethylamine SCHEMBL27972784 0.67 LOXL2 (0.58) ACHELMNAIDO1LOXL2TAAR1
SCHEMBL13994371 0.67 PLA2G1B (0.40) IDO1TAAR1NFE2L2
Water SCHEMBL27793704 0.67 ACHE (0.43) ACHELMNAIDO1LOXL2TRPA1
Ethylamine SCHEMBL27766150 0.65 LOXL2 (0.55) ACHELMNAIDO1LOXL2TAAR1
SCHEMBL13499 0.65 — —
SCHEMBL20864141 0.64 ALDH1A1 (0.53) LMNACA2TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230159762-A1 NIR TO SWIR FLUORESCENT COMPOUNDS FOR IMAGING AND DETECTION REVVITY HEALTH SCIENCES, INC. 2023-05-25 — — US disclosed
US-11549017-B2 NIR to SWIR fluorescent compounds for imaging and detection PERKINELMER HEALTH SCIENCES, INC. (US) 2023-01-10 — — US disclosed
US-20190100654-A1 NIR TO SWIR FLUORESCENT COMPOUNDS FOR IMAGING AND DETECTION REVVITY HEALTH SCIENCES, INC. 2019-04-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11549017-B2 NIR to SWIR fluorescent compounds for imaging and detection SMARCD1, SMARCE1, SMARCB1 ACHE 3586/4885LMNA 717/4885IDO1 1168/4885
US-20190100654-A1 NIR TO SWIR FLUORESCENT COMPOUNDS FOR IMAGING AND DETECTION SMARCD1, SMARCE1, SMARCB1 ACHE 3586/4885LMNA 717/4885IDO1 1168/4885
US-20230159762-A1 NIR TO SWIR FLUORESCENT COMPOUNDS FOR IMAGING AND DETECTION SMARCD1, SMARCE1, SMARCB1 ACHE 3586/4885LMNA 717/4885IDO1 1168/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback